Company / Income Tax
ARS Pharmaceuticals, Inc. Income Tax History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$80.0K
FY2025
5-year range
-$80.0K / $288.0K
FY2021-FY2025
Trend
-127.8%
vs FY2024
Sector context
#171 of 204
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s income tax of -$80,000 is lower than 84% of companies in the Health Care sector (FY2025). Improved from $0 to -$80,000 over the past 2 years.
Based on SEC 10-K filings.
-$80,000 in FY2025.
Improved from $0 to -$80,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 204This company -$80.0K Sector average $118.7M
▼
-100.1% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 127.8% year-over-year.
- Ranks #171 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$80.0K | -127.8% |
| FY2024 | $288.0K | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026